These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
166 related articles for article (PubMed ID: 26170739)
1. Antinociceptive Effects of Transcytosed Botulinum Neurotoxin Type A on Trigeminal Nociception in Rats. Kim HJ; Lee GW; Kim MJ; Yang KY; Kim ST; Bae YC; Ahn DK Korean J Physiol Pharmacol; 2015 Jul; 19(4):349-55. PubMed ID: 26170739 [TBL] [Abstract][Full Text] [Related]
2. Blockade of spinal glutamate recycling produces paradoxical antinociception in rats with orofacial inflammatory pain. Yang KY; Mun JH; Park KD; Kim MJ; Ju JS; Kim ST; Bae YC; Ahn DK Prog Neuropsychopharmacol Biol Psychiatry; 2015 Mar; 57():100-9. PubMed ID: 25445477 [TBL] [Abstract][Full Text] [Related]
3. Antinociceptive Effects of Botulinum Toxin Type A on Trigeminal Neuropathic Pain. Yang KY; Kim MJ; Ju JS; Park SK; Lee CG; Kim ST; Bae YC; Ahn DK J Dent Res; 2016 Sep; 95(10):1183-90. PubMed ID: 27418174 [TBL] [Abstract][Full Text] [Related]
4. Botulinum toxin type a antinociceptive activity in trigeminal regions involves central transcytosis. Nemanić D; Mustapić M; Matak I; Bach-Rojecky L Eur J Pharmacol; 2024 Jan; 963():176279. PubMed ID: 38123005 [TBL] [Abstract][Full Text] [Related]
5. Subcutaneous administration of botulinum toxin A reduces formalin-induced pain. Cui M; Khanijou S; Rubino J; Aoki KR Pain; 2004 Jan; 107(1-2):125-33. PubMed ID: 14715398 [TBL] [Abstract][Full Text] [Related]
6. Involvement of substance P in the antinociceptive effect of botulinum toxin type A: Evidence from knockout mice. Matak I; Tékus V; Bölcskei K; Lacković Z; Helyes Z Neuroscience; 2017 Sep; 358():137-145. PubMed ID: 28673722 [TBL] [Abstract][Full Text] [Related]
7. Intracisternal administration of NR2 antagonists attenuates facial formalin-induced nociceptive behavior in rats. Yang GY; Woo YW; Park MK; Bae YC; Ahn DK; Bonfa E J Orofac Pain; 2010; 24(2):203-11. PubMed ID: 20401359 [TBL] [Abstract][Full Text] [Related]
8. Central serotonin 3 receptors play an important role in the modulation of nociceptive neural activity of trigeminal subnucleus caudalis and nocifensive orofacial behavior in rats with persistent temporomandibular joint inflammation. Okamoto K; Kimura A; Donishi T; Imbe H; Senba E; Tamai Y Neuroscience; 2005; 135(2):569-81. PubMed ID: 16112478 [TBL] [Abstract][Full Text] [Related]
9. Reduction of TRPV1 expression in the trigeminal system by botulinum neurotoxin type-A. Shimizu T; Shibata M; Toriumi H; Iwashita T; Funakubo M; Sato H; Kuroi T; Ebine T; Koizumi K; Suzuki N Neurobiol Dis; 2012 Dec; 48(3):367-78. PubMed ID: 22820141 [TBL] [Abstract][Full Text] [Related]
10. Effects of intraplantar botulinum toxin-B on carrageenan-induced changes in nociception and spinal phosphorylation of GluA1 and Akt. Sikandar S; Gustavsson Y; Marino MJ; Dickenson AH; Yaksh TL; Sorkin LS; Ramachandran R Eur J Neurosci; 2016 Jul; 44(1):1714-22. PubMed ID: 27108664 [TBL] [Abstract][Full Text] [Related]
11. Peripherally Administered Botulinum Toxin Type A Localizes Bilaterally in Trigeminal Ganglia of Animal Model. Waskitho A; Yamamoto Y; Raman S; Kano F; Yan H; Raju R; Afroz S; Morita T; Ikutame D; Okura K; Oshima M; Yamamoto A; Baba O; Matsuka Y Toxins (Basel); 2021 Oct; 13(10):. PubMed ID: 34678997 [TBL] [Abstract][Full Text] [Related]
12. Role of central versus peripheral opioid system in antinociceptive and anti-inflammatory effect of botulinum toxin type A in trigeminal region. Drinovac Vlah V; Filipović B; Bach-Rojecky L; Lacković Z Eur J Pain; 2018 Mar; 22(3):583-591. PubMed ID: 29134730 [TBL] [Abstract][Full Text] [Related]
13. Botulinum toxin type A ameliorates adjuvant-arthritis pain by inhibiting microglial activation-mediated neuroinflammation and intracellular molecular signaling. Shi X; Gao C; Wang L; Chu X; Shi Q; Yang H; Li T Toxicon; 2020 Apr; 178():33-40. PubMed ID: 32250746 [TBL] [Abstract][Full Text] [Related]
14. Intracisternal NMDA produces analgesia in the orofacial formalin test of freely moving rats. Lee HJ; Choi HS; Jung CY; Ju JS; Kim SK; Bae YC; Ahn DK Prog Neuropsychopharmacol Biol Psychiatry; 2004 May; 28(3):497-503. PubMed ID: 15093957 [TBL] [Abstract][Full Text] [Related]
15. Antinociceptive Actions of Botulinum Toxin A1 on Immunogenic Hypersensitivity in Temporomandibular Joint of Rats. Muñoz-Lora VRM; Dugonjić Okroša A; Matak I; Del Bel Cury AA; Kalinichev M; Lacković Z Toxins (Basel); 2022 Feb; 14(3):. PubMed ID: 35324657 [TBL] [Abstract][Full Text] [Related]
16. Activation of alpha2-adrenoceptors in the trigeminal region produces sex-specific modulation of nociception in the rat. Nag S; Mokha SS Neuroscience; 2006 Nov; 142(4):1255-62. PubMed ID: 16934408 [TBL] [Abstract][Full Text] [Related]
17. Central action of peripherally applied botulinum toxin type A on pain and dural protein extravasation in rat model of trigeminal neuropathy. Filipović B; Matak I; Bach-Rojecky L; Lacković Z PLoS One; 2012; 7(1):e29803. PubMed ID: 22238656 [TBL] [Abstract][Full Text] [Related]
18. Anti-nociceptive effect of a conjugate of substance P and light chain of botulinum neurotoxin type A. Mustafa G; Anderson EM; Bokrand-Donatelli Y; Neubert JK; Caudle RM Pain; 2013 Nov; 154(11):2547-2553. PubMed ID: 23933181 [TBL] [Abstract][Full Text] [Related]
19. Botulinum toxin promotes orofacial antinociception by modulating TRPV1 and NMDA receptors in adult zebrafish. Rocha Barreto R; Lima Veras PJ; de Oliveira Leite G; Vieira-Neto AE; Sessle BJ; Villaça Zogheib L; Rolim Campos A Toxicon; 2022 Apr; 210():158-166. PubMed ID: 35167888 [TBL] [Abstract][Full Text] [Related]
20. Physiological contributions of neurokinin 1 receptor activation, and interactions with NMDA receptors, to inflammatory-evoked spinal c-Fos expression. Chapman V; Buritova J; Honoré P; Besson JM J Neurophysiol; 1996 Sep; 76(3):1817-27. PubMed ID: 8890294 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]